Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on June 11, 2026

Jun. 11, 2026

Dentsply Sirona Appoints John Fortson as Chief Financial Officer

Indeterminate GlobeNewswire

Jun. 11, 2026

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents

Indeterminate GlobeNewswire

Jun. 11, 2026

Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition

Indeterminate GlobeNewswire

Jun. 11, 2026

Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing

Indeterminate GlobeNewswire

Jun. 11, 2026

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 11, 2026

Imviva Biotech Presents Studies on CTD402 Allogeneic CAR-T Therapy at EHA2026 Congress

Indeterminate GlobeNewswire

Jun. 11, 2026

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Indeterminate GlobeNewswire

Jun. 11, 2026

RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 11, 2026

Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire

Jun. 11, 2026

Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control

Indeterminate GlobeNewswire

Jun. 11, 2026

TOMI Environmental Solutions Highlights Massive Biosecurity Opportunity Ahead of FIFA World Cup

Indeterminate GlobeNewswire

Jun. 11, 2026

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

Indeterminate GlobeNewswire

Jun. 11, 2026

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement

Indeterminate GlobeNewswire

Jun. 11, 2026

Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML

Indeterminate GlobeNewswire

Jun. 11, 2026

Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

Indeterminate GlobeNewswire

Jun. 11, 2026

FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM

Indeterminate GlobeNewswire

Jun. 11, 2026

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress 

Indeterminate GlobeNewswire

Jun. 11, 2026

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

Indeterminate GlobeNewswire